Medical Health & Life Science Research News

Cardiac marker analyzer market forecast to 2022 examined in new market research report

Cardiac marker analyzer market forecast to 2022 examined in new market research report

“Cardiac Marker Analyzer Product Analysis, Cardiac Marker Companies Business & Marketing Strategy” provides a comprehensive assessment of the cardiac markers analyzer segments, comparative tests analysis, competitive product analysis, product features & benefits, merger, acquisitions, strategic alliances and Companies Business and Market Strategies.

- Agency -.

Complete report available at www.marketreportsonline.com/647096.html.

Cardiac Marker Analyzer - Key Companies Analysis: Alere, Abbott Point of Care, Roche, Beckman Coulter, Siemens Healthineers, Response Biomedical, Boditech, Lifesign, LSI Medience Corporation, CardioGenics Holdings Inc. & Trinity Biotech

12 Cardiac Marker Analyzer Covered in the report are as follows: Triage MeterPro Analyzer, The i-STAT System, Cobas h 232 POC System, Access 2 Immunoassay System, Stratus CS Analyzer, RAMP 200, RAMP Reader, i-chroma DUO Analyzer, DXpress Reader Analyzer, PATHFAST Analyzer, QL Care Analyzer & Meritas POC Analyzer

Cardiac Marker analyzer represents a paradigm in diagnostics that provides high sensitivity and reliable information in minutes.

- Agency -.

It is ideally suited to both point of care testing and laboratory use. The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment.

Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state and used for diagnostic and prognostic purposes associated with heart.

Access a copy of this “Cardiac Marker Analyzer Product Analysis” research report at www.marketreportsonline.com/contac….php?name=647096.

Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others.

The factors such as increasing incidences of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public-private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the market. However, factors such as technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are some of the key factors hampering the growth of this market.

Key Highlights of the Cardiac Marker Analyzer Market Report

Within the professional diagnostics business segment, Alere cardiometabolic net product sales and services revenue decreased by 12% in 2016.

In April 2017, Abbott and Alere Inc. announced that the companies have agreed to amend the existing terms of their agreement for Abbott's acquisition of Alere.

In 2016, Abbott Point of Care Diagnostics sales increased to over US$ 500 Million.

Cobas H232 POC system permits rapid and easy determination of cardiac blood markers such as Troponin T, NT-proBNP, D-dimer, CK-MB and myoglobin.

A major focus of Response Biomedical development programs in cardiovascular testing has been clinical tests for the quantification of cardiovascular markers.

In February 2017, Siemens Healthineers announced a digital platform for healthcare providers as well as for providers of solutions and services.

Response Biomedical cardiovascular sales is likely to reach US$ XX Million by 2022.

Trinity Biotech Point-of-Care revenues for 2017 is likely to decline.

In Jan. 2017, Abbott completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena.

Major Points from Table of Contents (www.marketreportsonline.com/647096.html) Covered in Global Cardiac Marker Analyzer Market Report:

1. Executive Summary

2. Cardiac Marker Companies - Comparative Tests Analysis

3. Cardiac Marker Analyzer - Competitive Product Analysis

4. Alere
4.1 Alere Triage
4.1.1 Triage MeterPro Analyzer
4.1.2 Alere Cardiology Net Sales & Forecast (2010 - 2016)

5. Abbott Point of Care
5.1 The i-STAT System
5.2 Abbott Laboratories Point of Care Diagnostics Sales (2011 - 2022)

6. Roche
6.1 Cobas h 232 POC System

7. Beckman Coulter
7.1 Access 2 Immunoassay System

8. Siemens Healthineers
8.1 Stratus CS Analyzer
8.2 Siemens Healthineers establishes global Digital Ecosystem to drive Digitalization of Healthcare

9. Response Biomedical

News From

MarketReportsOnline - Industry Research Analysis StoreMarketReportsOnline
Category: Market Research Publishers and RetailersCompany profile: MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.